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Abstract—Molecular communication is an important tool to
understand biological communications with many promising
applications in Internet of Bio-Nano Things (IoBNT). The insulin-
glucose system is of key significance among the major intra-
body nanonetworks since it fulfills metabolic requirements of
the body. Study of biological networks from information and
communication theoretical (ICT) perspective is necessary for
their introduction in the IoBNT framework. Therefore, the
objective of this work is to provide and analyze for the first
time in literature, a simple molecular communication model of
the human insulin-glucose system from ICT perspective. The
data rate, channel capacity and the group propagation delay are
analyzed for a two-cell network between a pancreatic beta cell
and a muscle cell that are connected through a capillary. The
results point out a correlation between an increase in insulin
resistance and a decrease in the data rate and channel capacity,
an increase in the insulin transmission rate and an increase in the
propagation delay. We also propose applications for introduction
of the system in IoBNT framework. Multi-cell insulin glucose
system models may be based on this simple model to help in
the investigation, diagnosis and treatment of insulin resistance
by means of novel IoBNT applications.
Index Terms—Internet of Bio-Nano Things (IoBNT), Insulin-
glucose system, ICT-based modeling, Molecular communication,
Insulin resistance
I. INTRODUCTION
The vision of a cyber-physical paradigm that connects
physical elements to each other for autonomous commu-
nication has allowed Internet of Things (IoT) to become
a focus for major research and development efforts. With
advances in nanotechnology and communication engineering,
Internet of NanoThings (IoNT) was proposed to be based
on synthesized materials, electronic circuits, and interaction
through electromagnetic waves [1]. In contrast, Internet of
Bio-Nano Things (IoBNT) was proposed with a focus on
biological communications [2]. Under the IoBNT umbrella,
biological cells are controlled using biochemical stimuli to
perform operations such as intra-body sensing, actuation, and
connectivity control.
A number of recent studies target the IoBNT field. In [3],
analog filters that can be used as components for IoBNT
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systems are proposed. The model for a bio-cyber interface for
an advanced healthcare delivery system is proposed in [4]. A
silicon nanowire BioFET as a molecular antenna for bio-cyber
interfaces is proposed in [5]. IoBNT architecture revolves
around the capability to communicate with biological entities
and the quality of a communication network, its limitations and
the supported rates can be quantified through an information
and communication theory (ICT) study of the system. Thus, a
key motivation for an ICT study of a biological system is its
eventual integration in the wider IoBNT framework.
Molecular communication (MC) is suggested as the commu-
nication scheme between biological entities and their bio-cyber
interfaces in IoBNT. Systems based on bio-nanomachines can
be found all around and within us [6], [7]. Understanding this
molecular signaling among living cells from ICT perspective
provides novel nanonetworking directions and a deep insight
into the ICT-based fundamentals of biological systems [6].
Several ICT models exist in literature for key MC systems
of the human body such as the nervous system [8], [9], [10]
and the gap junction communication between cardiomyocytes
[11], however, to date no work targets an endocrine system
from this perspective. Since the endocrine systems operate on
the principles of MC, a study of the MC in these systems
may give rise to an in-depth analysis of the system from a
new perspective to produce novel diagnostic, management and
treatment applications based on MC principles.
Endocrine system is a set of glands that produce hormones
to control important functions of the body such as metabolism,
growth, development, reproduction and emotions. Due to its
sheer importance in metabolism, a huge body of literature
focuses on the insulin-glucose endocrine system. Insulin regu-
lates blood glucose by assisting its uptake in the body cells. It
is produced in specialized pancreatic cells known as the beta
cells. In cases when the pancreas does not produce enough
insulin or when the body cannot effectively use the insulin it
produces, a set of conditions known as diabetes occur. Since
the insulin-glucose system effects the metabolism of other
nanonetworks such as the nervous system, diabetic conditions
affect them adversely as well [12]. Several mathematical
models for the biochemical processes involved in the insulin-
glucose system are described in literature [13], [14]. These
models either take a higher level approach based on serum
concentrations of insulin and glucose, describe the biochemical
kinetics of the system or both of these in some cases. Since
most diagnostic, management and treatment applications of
the insulin-glucose system are based on MC, it is essential to
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Fig. 1: Key steps of insulin-glucose system: (1) Uptake of
glucose by the beta cell, (2) Glucose metabolism in the beta
cell, (3) Insulin vesicle exocytosis as a result of metabolism,
(4) Insulin and glucose transport by the circulatory system,
(5) Insulin binding to insulin receptors at muscle cells, (6)
Glucose transporter exocytosis as a result of insulin binding,
(7) Glucose binding with glucose transporters and (8) Glucose
transport and metabolism within the muscle cell.
model this communication such that methods to improve sys-
tem performance may be discovered and IoBNT applications
for this system may be realized. Therefore, in this paper, we
model a simple MC system between a beta cell and muscle cell
connected by means of a capillary. Expressions for data rate,
bounds for channel capacity and ranges for group propagation
delay are derived and the effects of insulin resistance on these
communication parameters are discussed. These expressions
may be used in further ICT-based models of insulin-glucose
system where multi cell to multi cell connections are explored.
We discuss the effect of insulin resistance on the derived ICT
parameters for Type II diabetes patients. To our knowledge,
this is also the first work on the ICT-based modeling of a
hormonal communication channel. We also propose potential
applications of IoBNT in insulin-glucose system.
The rest of this paper is organized as follows. Section
II describes the insulin-glucose system that includes insulin
secretion by beta cell, molecular circulation through capillaries
and glucose uptake by muscle cell. ICT-based model and
analysis of the system is presented in Section III. In Section IV,
we present our numerical analysis based on simulations. The
relationship between insulin resistance and data rate, channel
capacity, propagation delay, and information transmission rate
is explored in Section V. Applications of IoBNT in insulin-
glucose system management are proposed in Section VI.
Finally, Section VII concludes this work.
II. INSULIN-GLUCOSE SYSTEM
In the insulin-glucose system, communication between a
pancreatic beta cell and a muscle cell occurs by means of the
circulatory system between them. Key steps of this process
are illustrated in Fig. 1. In this section, we first present a
description of the system that we model and then present
processes of insulin release, transport and glucose uptake in
detail.
A. System Description
The human body is a complex system where a number
of processes that are controlled by various organs work co-
operatively. For instance, liver is the primary site of insulin
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Fig. 2: System description for a cell-to-cell communication
system between a beta and a muscle cell.
clearance in the human body, where approximately 80% of
endogenous insulin is removed while the remainder is cleared
by the kidneys and muscles, and the human heart provides
the pumping force to deliver the blood to various parts of the
body [15]. The modeling of all these organs along with all
the different types of body cells is beyond the scope of any
single study and therefore, in the current study, a hypothetical
control system is assumed to perform functions similar to those
performed by a number of organs in the human body such as
the heart, liver, stomach, kidneys and muscle cells other than
the target receiving cell. The purpose of assuming a control
unit that oversees all these operation is to isolate a single beta
and muscle cell only such that their mutual communication
can be focused in detail.
In our model, we consider that a unit volume of the same
blood is being circulated by an external control source through
a capillary with an average velocity, vavg as shown in Fig. 2.
The capillary runs from a region that includes a beta cell in
the extracellular space towards a region with a muscle cell in
the extracellular space. We assume that the conditions on the
boundaries of the capillary are such that the blood leaving the
muscle cell end enters from the beta cell end to complete the
circulation path.
Apart from pumping, the control source is responsible for
controlling the insulin concentration I(t) between a min-
imum I0 and a maximum level Imax. Similarly, glucose
concentration G(t) is maintained between G0 and Gmax.
These considerations ensure that the system does not suffer
a runaway condition where either insulin or glucose increases
in an unbounded manner. In a real life scenario, the minimum
concentration of glucose and insulin can be calculated by
a fasting glucose test whereas the maximum concentration
can be calculated by a glucose tolerance test. Additionally,
the control source is also responsible for fixed removal of
insulin and glucose with rates l1 and l4, respectively, for the
introduction an external glucose impulses, δ(t), into the system
if required, and to maintain the temperature of the system
on a physiological value of 37◦C. The assumptions provided
above are similar to those in the human body under normal
physiological conditions and mimic the effects of various
organs such as the heart, liver and the stomach.
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Fig. 3: Insulin secretion as a result of glucose uptake by a beta
cell.
B. Insulin Secretion
The complete process of insulin secretion from a beta cell
is detailed in Fig. 3. The introduction of meal impulse, δ(t),
increases G(t) and thus, the probability of glucose molecule
reception by the beta cells, P (BG), though their GLUT2
glucose sensors [16]. Once received, the glucose is transported
inside the cell to be metabolized. This causes the concentration
of Adenosine triphosphate (ATP) to increase, which, in turn,
causes the ligand-gated K+ channels to shut down. Thus,
the membrane potential starts to increase since K+ ions are
not flowing out anymore. Increase of membrane potential
causes the voltage-gated Ca++ channels to open and an inflow
of Ca++ ions occurs. The increased membrane potential
causes insulin vesicles to move towards the cell membrane,
where insulin is released by exocytosis [17]. All the processes
described above are governed by chemical kinetics and the
values of most kinetic constants are already known in literature
[14].
The insulin concentration is based on the average clearance
rate of insulin, its nominal release rate without glucose and
the net increase of insulin release rate due to the presence of
glucose [18]. The change of insulin concentration, i.e. I(t)
with respect to time can be described by
dI(t)
dt
= −l1I(t) + nI + l3G(t), (1)
where l1I(t) represents the average rate of insulin clearance
independent of glucose, nI is the average rate of basal insulin
release by the beta cell independent of glucose and l3G(t)
is the net increase in the rate of insulin release as a result
of increase in glucose concentration G(t). Since the insulin
leakage governed by nI is independent of any glucose impulse,
it represents a source of noise in the secretion process.
The probability of glucose molecule reception by the beta
cells, P (BG), is directly proportional to the glucose concen-
tration G(t) and the number of GLUT2 transporters present
on the surface of the beta cell. P (BG) can be expressed as
P (BG) =
G(t)−G0
Gmax −G0 ×
Nact2
NGLUT2
, (2)
where Nact2 is the number of unbound GLUT2 transporters
on the surface of a beta cell and NGLUT2 represents the total
number of GLUT2 receptors in a beta cell. After a glucose
impulse, G(t) increases above G0 causing an increase in
P (BG). The same happens if the number of GLUT2 receptors
on the surface of a beta cell increase to fulfill the metabolic
requirements of the beta cell. I(t) also depends on P (BG)
since the release of insulin depends on the glucose sensing by
the GLUT2 transporters.
C. Circulation
Blood circulation provides the mechanism for insulin and
glucose delivery to the beta and the muscle cells. In a normal
human body, this transport occurs through various arteries and
veins of the body that are then connected by networks of
capillaries. Capillaries are the smallest type of blood vessels
ranging from 5 to 40µm in diameter with characteristic high
surface area to volume ratios that maximizes the potential for
blood-tissue exchange [19].
Considering the case of two specific cells connected through
a capillary, there are three important components of the
transport for insulin molecules as shown in Fig 2. These are
• diffusion of the molecules from the beta cell towards the
capillary,
• transport through the capillary, and
• diffusion from the capillary to the muscle cell.
For diffusion towards and from the capillary, we consider
that the forces of flow inside the capillary do not effect the
insulin molecules. Thus, this movement of molecules in the
extracellular space can be modeled by Brownian motion that
results from thermal motion of molecules within the fluid.
We ignore collisions between the messenger molecules, as
reported extensively in the literature for MC [8], [10], [20],
[21], therefore the molecule experiences Gaussian displace-
ment. The diffusion equation describes diffusion as
∂I(x, t)
∂t
= D∇2I(x, t), (3)
where I(x, t) denotes the insulin concentration and D denotes
the diffusion coefficient which depend on temperature, pres-
sure and the viscosity of the blood. Equation (3) is linear time-
invariant and the solution in an n-dimensional space from a
position x is calculated by the Green’s function as
Gr(x, t) = (4piDt)−n/2e
−(x−x′)2
4Dt . (4)
Note that (4) indicates how a point of probability density
initially at point x diffuses over n-dimensional space and time
existing under the condition of normalization given as∫ ∞
−∞
Gr(x, t)dx = 1, (5)
where the normalization is achieved by the multiplication
of a normalization constant that is calculated numerically.
Inside the capillary, insulin molecules are transported by the
blood flow. This causes a convective flow process where along
with the flow forces, diffusion of the particles also occurs.
Reynold’s number is used to help predict flow patterns in
different fluid flow situations with low Reynold’s numbers
characterizing laminar flows and high Reynold’s numbers
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Fig. 4: Glucose uptake by a muscle cell as a result of insulin
binding.
representing turbulent flow. The Reynold’s number, Re, is
given as
Re =
ρvavgdH
ν
, (6)
where ρ is the fluid density, vavg is the mean fluid velocity, dH
is the hydraulic diameter and ν represents the fluid viscosity.
The Reynold’s number for capillaries is very low, i.e. 0.001
meaning that there is laminar flow within capillaries that
causes flow in parallel layers with no mixing between the
layers [19]. This leads to the conclusion that Brownian motion
within the capillary can be neglected on a microscale in
comparison to the laminar flow forces [22].
Therefore, the average propagation time for insulin
molecules from a beta cell through a capillary with length
L to a muscle cell is given as
TC =
L
vavg
+
∫ ∞
0
tGrb(x, t)dt+
∫ ∞
0
tGrm(x, t)dt. (7)
Here, Grb(x, t) represents the normalized Green’s function
diffusion from the beta cell to the capillary and Grm(x, t)
represents the normalized Green’s function diffusion from the
capillary to the muscle cell.
D. Glucose Uptake
GLUT1 and GLUT3 glucose transporters are available
throughout the cells of muscles and tissues to maintain a
basal uptake of glucose [23]. However, since for the current
study we look at the insulin mediated glucose uptake, they
are neglected in Fig. 4, which shows the process of glucose
uptake by a muscle cell. The muscle cell begin glucose uptake
when insulin molecules bind to insulin receptors present on
the cell membrane. Insulin receptors are protein molecules
that can bind to smaller insulin ligands that act as agonist,
making the receptor to function. Until this happens, ‘GLUT4’,
the major insulin dependent glucose transporters, remain in
vesicles inside the cell. As soon as the insulin binds, signals
are sent to the GLUT4 vesicles and exocytosis of the vesicles
starts [17]. This, in turn, allows GLUT4 to transport glucose
inside the cell that is then used for metabolism. Outside the
cell, overall glucose concentration decreases as a result of the
uptake. This then reduces the production of insulin from beta
cell as well [18].
The change in glucose concentration is a sum of average
blood glucose removal rate, release of glucose by the control
unit independent of δ(t), its insulin mediated glucose uptake
and δ(t) that leaves the system with a big concentration of
glucose [18]. This can be expressed as
dG(t)
dt
= −l4G(t) + nG − l6I(t) + δ(t), (8)
where l4G(t) represents the average rate of glucose removal
independent of insulin, nG is the average rate of basal glucose
release and l6I(t) is the net increase in the rate of glucose
uptake due to the presence of insulin. Similar to the secretion
process, nG represents a noise source in the glucose uptake
process that can be
The probability of insulin reception at the muscle cell,
P (MI), is directly proportional to the insulin concentration
I(t) as well as the number of insulin receptors present on the
cell. Therefore, P (MI) can be written as
P (MI) =
I(t)− I0
Imax − I0 ×
Nub
Nt
. (9)
Here, Nub is the number of unbound insulin receptors and Nt
represents the total number of insulin receptors on the cell
membrane of a muscle cell.
In case of a fasting test, a person is not allowed to have
any food for 8 to 12 hours before the test [18]. This lack of a
digestive impulse δ(t) forces I(t) and G(t) to their minimum
values I0 and G0, respectively. Additionally,
dI(t)
dt = 0 and
dG(t)
dt = 0, since there are no changes in the insulin or glucose
concentrations. For such a scenario, (1) and (8) can be written
as
nI = l1I0 − l3G0, (10)
nG = l4G0 + l6I0. (11)
Equations (1), (8), (10) and (11) can be used to give a
solution for glucose concentration G(t) similar to [18]
G(t) = G0 +Ae
−αt sin(ωt) (12)
where A is the undamped amplitude, α = 12 (l1+l4) represents
the independent clearance rates of glucose and insulin, and
ω2 = ω20 − α2 with the natural response ω20 = l1l4 + l3l6
representing the control unit’s response.
III. INFORMATION THEORETIC MODEL OF
INSULIN-GLUCOSE SYSTEM
For the information theoretical model of the insulin-glucose
system, we consider insulin and glucose as information
molecules. Although these molecules occupy the same physi-
cal channel (capillary), they operate in two different channels
as illustrated in Fig. 5.
As an abstraction of MC in the forward channel, we
consider the release of insulin molecules by the beta cell as
a transmission process. This transmission occurs based on the
feedback of glucose concentration by the GLUT2 transporters.
Each insulin molecule is considered as an independent trans-
mission bit that may be received by the muscle cell separately
to constitute the reception process. It should be noted here that
since all insulin molecules are similar, the information they
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Fig. 5: ICT model of insulin-glucose system.
carry is also similar. After the reception process, the muscle
cell uptakes glucose from the blood stream by exocytosis of
GLUT4.
In the feedback channel, depending on the uptake of glucose
by the muscle cell, glucose concentration changes. Thus,
glucose molecules constitute the information carriers of the
feedback channel. The purpose of this feedback channel is
to communicate the channel state information (CSI) with both
the transmission (by beta cell) and the reception processes (by
muscle cell). The management of the feedback channel is the
primary responsibility of the control unit as evident from (12).
A. Channel Capacity
In the current scenario, we define channel capacity as the
maximum number of insulin molecules that can be commu-
nicated per unit time. On a molecular observation scale, each
insulin receptor on the muscle cell works independently, and
each molecule that is communicated constitutes a different
data reception event. Considering Nt as the total number of
transmitted insulin molecules at a particular instant in the unit
volume supported by the control unit, I(t) is related to Nt as
[24]
Nt = 7.174× 10−12 ×Av × I(t), (13)
where Av is a Avogadro’s number. Even for a unit concen-
tration of insulin per mL, the above number is quite large in
comparison to the total number of receptors (Nr) available on
the muscle cell.
The instantaneous data rate of the insulin-glucose system
is equal to the number of insulin-insulin receptors bindings at
any time. Thus, the change of data rate with respect to time is
equal to receptor binding rate of insulin at the receiver muscle
cell that is governed by the kinetic equation
∂R(t)
∂t
= kfI(t)Nub − krR(t), (14)
where R(t) is the instantaneous data rate of the insulin-
glucose system that represents the number of insulin-receptor
bound pairs, kf is the forward binding rate of insulin and
kr is the reverse binding rate with the values of kf , and kr
already provided in literature [14]. Insulin concentration and
receptor density at the receiver both are important factors that
contribute towards a higher data rate.
At equilibrium, the data rate change becomes zero (∂R(t)∂t =
0) and the equilibrium data rate is given as
Req =
NeqIeq
kD
, (15)
where Neq is the number of unbound receptors at equilibrium,
Ieq is the equilibrium concentration of insulin and kD = kr/kf
is disassociation equilibrium constant. For the small values that
kD typically has, the capacity of the muscle cell turn out to be
high. If we compare two scenarios for the reception, one with
a higher kD and the other with a lower kD, the data rate will
be higher in the second case, and thus it will be able to detect
smaller changes in the concentration of insulin in comparison
to the first system. The equilibrium is an important point for
the calculation of data rate since the number of insulin-insulin
receptor pairings equals the number of separations.
The total number of receptors, Nr, is a sum of bound
receptors, Req and the unbound receptors, Neq . Therefore, (15)
can be modified as
Req =
(Nr −Req)Ieq
kD
, (16)
which can be solved for equilibrium capacity as
Req =
NrIeq
kD + Ieq
. (17)
Since channel capacity is the maximal bound of data rate,
we consider the case when negligible noise and attenuation is
faced by transmitted insulin molecules in the channel. This
results in the receivers acting as parallel channels and the
channel capacity equals the least number of transmissions or
receptions, or the maximum number of insulin molecules that
can be contained in a capillary provided the receptors and
insulin molecules are infinite, i.e.,
C = min(Nt, Nr, Nmax), (18)
where Nmax represents the maximum number of insulin
molecules that can be contained in the capillary. The diameter
of capillaries is several orders of magnitude higher than that of
an insulin molecule, therefore, usually min(Nt, Nr). As stated
earlier, the number of insulin receptors is normally much less
than the number of insulin molecules to facilitate the easy
binding of insulin. Therefore, under normal cellular operation
C = Nr. This, however, may not be the case every time
because insulin pools present in a beta cell can be spent as a
result of disease or persistent glucose impulses. In such cases,
C = Nt.
B. Channel Propagation Delay
The average channel propagation delay for a group of
insulin molecules to traverse from the beta cell to receivers on
the muscle cell in a first-hit scenario is a sum of the time taken
for vesicle release Tves, time taken for capillary propagation
TC and the time required for binding with the insulin receptors
at the muscle cell Tbind. This delay increases in case either of
P (BG) or P (MI) reduce [14], [25]. Therefore, total average
group delay T is given as
T =
1
P (BG)× P (MI) (Tves + TC + Tbind). (19)
6TABLE I: Values of key physiological variables [26], [27],
[28].
Parameter Physiological Value
vavg 1.14mm/sec
kD 3nm
Tves 100msec
Tbind 100msec
Body temperature 37◦C
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Fig. 6: Effect of insulin concentration on equilibrium data rate
for different number of insulin receptors.
The probability product, P (BG) × P (MI), plays the most
important part in increasing the propagation delay. As we will
see in the Section V, physiological diseases cause either one
or both of these parameters to decrease, increasing the overall
propagation delay.
The TC in (19) can be the delay for a single capillary or the
transport through various arteries and capillaries. In [29], the
authors present a detailed model of transport through larger
regions of circulatory system that may be employed in case
larger networks are considered. It should be noted that vesicle
release and insulin binding are usually on the order of a few
hundred milliseconds, whereas the transport delay through a
capillary and the diffusion from the capillary usually takes up
several seconds [28], [26]. Therefore, for a capillary with a
sufficiently long length or for a large network of blood vessels,
Tves and Tbind may be neglected.
IV. NUMERICAL ANALYSIS
In this section, we present numerical analysis of the insulin-
glucose model for the data rate, insulin transmission rate and
the group propagation delay to show how these parameters
change with the properties of the system.
For the numerical analysis, we consider a single beta cell
connected to a muscle cell through a capillary channel as
shown in Fig. 1. The distance between the capillary and either
of the cells is considered as unit to simplify the diffusion
analysis. Important values for various physiological variables
used for the current analysis are presented in Table I.
A. Data Rate
Using (17), we can evaluate equilibrium data rate, Req ,
for various insulin concentrations. Ieq values between 4 −
12µU/mL are selected from human physiology and results
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Fig. 7: Effect of data rate on insulin concentration for different
number of equilibrium receptors.
are generated for different number of insulin receptors (Nr).
The various values of Nr used for the simulation are provided
for mammalian cell physiology in [30].
The result of the simulation is shown in Fig. 6. We can
observe that Req increases with an increase in the insulin
concentration. However, this increase slows down at higher
concentrations. The result also shows that Req is proportional
to the total number of insulin receptors present on the cell
surface. However, we also note that only a small percentage
of the total receptors are used in the reception process and the
maximum limit of capacity from (17) for each of the cases
may be achieved only at very high concentrations of insulin.
Since Imax is regulated by the control unit, the system cannot
go beyond that point to a higher value. Additionally, high
concentrations are beyond the levels of normal insulin con-
centration in the normal human body. This means that under
normal conditions, the insulin-glucose operates much below its
theoretical maximal capacity limits, thus, ensuring a reliable
information transfer across the system. This behavior is seen
in many biological MC systems, which operate much below
the maximal capacity bounds to ensure reliable information
transfer [6].
B. Insulin Transmission Rate
In order to observe the impact of data rate on the insulin
concentration, which acts as a measure of insulin transmission
rate, Fig. 7 is generated using (15). Firstly, the result shows
that Neq is inversely proportional to the Ieq required to achieve
a certain data rate. Secondly, we observe that as data rate
increases, the insulin concentration required to achieve it
increases in an unbounded manner. Though not shown by the
current figure, this unbounded increase cannot go beyond Imax
set by the control system and in such a case the system goes
into a saturation. An unbounded increase is practically not
possible in the human body for the pancreatic beta cell because
the insulin pools in a beta cell can provide insulin up to a
certain level before depleting the reserves and any regeneration
may need further time. Physically such conditions drive the
beta cell in an overdrive mode to produce more insulin and
reduce the overall cell life.
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C. Channel Propagation Delay
Considering 1-dimensional diffusion, the probability density
functions (PDF) of TC , the average propagation delay for
a group pf insulin molecules through capillaries of various
lengths, is shown in Fig. 8 using (4), (5) and (7) in a first-
hit scenario. TC is proportional to capillary lengths, however,
it can be observed that delays due to diffusion are also
quite significant. This means that diffusive delays cannot be
neglected for analysis of capillary based transport systems for
short lengths of capillaries.
The effects of probability product P (BG)× P (MI) on the
total propagation delay is shown in Fig. 9. The result shows
that as the probability product increases, the delay decreases.
In the absence of a glucose impulse, P (BG) reduces, and
thus the product term increases the overall average propagation
delay. Similarly, if insulin concentration is reduced, P (MI)
increases the average propagation delay.
V. INSULIN RESISTANCE AND ICT-BASED METRICS FOR
THE INSULIN-GLUCOSE SYSTEM
As of 2014, among the population that suffers from diabetes,
90% cases suffer from Type 2 Diabetes that is characterized
by insulin resistance [31]. Insulin resistance is a physiological
condition, where the body cells fail to respond to insulin and
reduce the uptake of glucose leading to a high blood sugar
level [32]. Beta cells subsequently increase their production
of insulin, further contributing to a high blood insulin level.
TABLE II: Effect of diabetes on trends of different communi-
cation parameters as a result of insulin resistance and reduced
insulin production.
Parameter Insulin Resistance Reduced Insulin
Production
Number of receivers ↓ no effect
Number of transmitters no effect ↓
Data rate ↓ ↓
Channel capacity ↓ ↓
Transmission rate ↓ ↓
Propagation delay ↑ ↑
Since the body cells cannot uptake glucose for metabolism, the
energy production of the body decreases [32]. As the disease
progresses, the insulin production itself decreases as a result of
diminished insulin pools in the beta cells and premature death
of beta cells. The effects of these conditions on the trends of
data rate, channel capacity, transmission rate and propagation
delay are summarized in Table II. We discuss the details of
these scenarios further in the following.
A. Effects on Data Rate and Channel Capacity
A significant number of insulin receptors do not activate in
response to insulin binding as a result of insulin resistance
[33]. This causes a failure in the reception process and slows
down the glucose uptake. From the perspective of the model
presented, this means a reduction Nr present on the muscle
cells. Equation (13) shows us that Nt is quite high in com-
parison to Nr. Additionally, from (17) and (18), we see that a
reduction in Nr affects the data rate since the bound of chan-
nel capacity for the insulin-glucose system is the maximum
number of receptor present on the muscle cells. Therefore,
both the data rate and the channel capacity of the insulin-
glucose system decrease as a result of insulin resistance. This
inference is also possible from Fig. 6, where we see that the
number of insulin receptors is directly proportional to data
rate. The case for reduced insulin production is also similar,
where a reduction in the insulin concentration decreases the
overall channel capacity.
B. Effects on Insulin Transmission Rate
Since the effective number of insulin receivers decreases as
a result of insulin resistance, we observe from (15) and Fig.
7 that the production of insulin also increases. This results
in high blood insulin, which is a major symptom of Type 2
diabetes [34]. Additionally, since the beta cell is forced to
produce higher amounts of insulin, it needs to work more
and this eventually causes the cell life to reduce. This often
happens in late diabetes cases, where starting from insulin
resistance, the beta cells are lost as well, thus, compounding
the problems of a diabetic patient [31].
C. Effects on Channel Propagation Delay
The concentration of both glucose and insulin increases
as a result of insulin resistance. At first glance, this may
seem like an increase in both P (BG) and P (MI) and such a
scenario should reduce the average channel propagation delay,
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Fig. 10: Applications of insulin-glucose system towards IoBNT.
however, this is not the case. Studies have found the reduction
of insulin receptors during insulin resistance by goes up to
75 − 80% of their total numbers [35]. This reduces P (MI)
by (9) and causes a reduction in the corresponding number
of active GLUT4 transporters at the muscle cell membrane.
Thus, the overall effect is an increase in the average channel
propagation delay of the insulin-glucose system.
VI. INSULIN-GLUCOSE SYSTEM TOWARDS IOBNT
Insulin-glucose system can be the target of a number of
important IoBNT applications. In the following we discuss
some possible application that aim towards the introduction of
insulin-glucose system described in the current work towards
the IoBNT framework.
A. IoBNT Connected Insulin Pumps
Efficient insulin supply by means of subcutaneous insulin
pumps can be an important step towards diabetes management.
Subcutaneous insulin pumps are already realized [36], [37],
however, the current generation of insulin pumps is offline,
where standalone insulin pumps with a small supply of insulin,
release it at preprogrammed times or according to the local
glucose concentration of the body area surrounding the pump.
We envision that these device can be operated online as
a part of the IoBNT framework as shown in Fig. 10 (a).
Important parameters for diabetes management such as insulin
and glucose concentrations can be directly communicated to
health care providers in such systems. Apart from the obvious
benefit of providing detailed disease progression being online,
the proposed systems can improve pump efficiencies by several
orders making the insulin cartridge last longer. Such systems
can also protect the body from the effects of excessive blood
insulin [38].
B. Cyber-Interfaced Beta Cell Implants
Implantation of pancreatic islets is suggested by some ex-
periments to manage insulin-dependent diabetic patients [39].
As an application of IoBNT, we propose that insulin pumps
may be replaced altogether by cyber-interfaced beta cells that
can be implanted as systems for the manufacture of insulin
upon triggers from IoBNT remote health monitoring setups as
shown in Fig. 10 (b). The analysis we presented in this paper
can also be considered for such a scenario where a cyber-
connected beta cell is interface with a muscle cell.
C. Energy Harvesting for IoBNT Applications
Since the insulin-glucose system is metabolically connected
with other networks of the body, it may also be considered as
an energy resource for intra-body IoBNT implants. In such
cases, bio-cyber interfaces, sensors, actuators and even syn-
thesis of drugs may be powered by the energy supplied by the
insulin-glucose system. These systems require the biological
implants to be engineered with glucose receptors and insulin
receptors. Our analysis in this work remains aligned with goal
if such a IoBNT implant is considered instead of a muscle
cell.
VII. CONCLUSION
In this paper, we provide and analyze a molecular com-
munication model of the insulin-glucose system from the
ICT perspective. Insulin and glucose molecules are consid-
ered as modulated molecular information carriers. These two
molecules operate simultaneously in the system in a single
physical channel, making a forward and a feedback channel
operating on insulin and glucose molecules, respectively. The
data rate, channel capacity, propagation delay for a group
of insulin molecules and the insulin transmission rate are
analyzed for a two-cell network between one pancreatic beta
cell and a receiving muscle cell, connected through a capillary.
Reduction in the number of receptor elements due to insulin
resistance is also investigated. The results of analyses point
out a correlation between an increase in insulin resistance and
a decrease in the data rate and channel capacity, an increase
in the transmission rate and an increase in the propagation
delay. The model and results of this work may help in the
investigation, diagnosis and treatment of insulin resistance by
means of novel ICT-based technologies. Further research on
the connections between major nanonetworks of the body such
as the nervous system and the insulin-glucose system may
benefit from this work. The model may pave way for future
applications of IoBNT such as the management of insulin
resistance by increasing the efficiency of insulin pumps.
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